Canadian Arthritis Patient Alliance (CAPA) was offered an opportunity to provide feedback related to Health Canada’s Consultation: Handbook for healthcare professionals on biosimilar biologic drugs. CAPA has a Medical Advisory Committee (MAC), and all of our resources including this input submission, are reviewed by at least one member of our MAC.